COVID-19 antibody ‘cocktail’ discovered at VUMC protects chronically ill
by Bill Snyder A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults…